{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T02:13:47Z","timestamp":1772590427517,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s11060-023-04427-y","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T02:02:15Z","timestamp":1693533735000},"page":"431-436","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Durable tumor regression and restoration of neurologic function after treatment with anti-PD-1 in patients with functionally unresectable cutaneous squamous cell carcinoma with perineural spread into the cavernous sinus"],"prefix":"10.1007","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2172-2120","authenticated-orcid":false,"given":"Andrew R.","family":"Carey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6625-448X","authenticated-orcid":false,"given":"Govind","family":"Warrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6715-0922","authenticated-orcid":false,"given":"Jenny K.","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6114-090X","authenticated-orcid":false,"given":"Megan D.","family":"Schollenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2976-0911","authenticated-orcid":false,"given":"Evan J.","family":"Lipson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7175-0413","authenticated-orcid":false,"given":"Nicholas R.","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"key":"4427_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3892\/mco.2023.2624","volume":"18","author":"DC-E Iancu","year":"2023","unstructured":"Iancu DC-E, Fulga A, Vesa D et al (2023) Insight on common forms of cutaneous head and neck carcinoma (Review). Mol Clin Oncol 18:28. https:\/\/doi.org\/10.3892\/mco.2023.2624","journal-title":"Mol Clin Oncol"},{"key":"4427_CR2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/00041327-199709000-00005","volume":"17","author":"MW ten Hove","year":"1997","unstructured":"ten Hove MW, Glaser JS, Schatz NJ (1997) Occult perineural tumor infiltration of the trigeminal nerve. Diagnostic considerations. J Neuroophthalmol 17:170\u2013177","journal-title":"J Neuroophthalmol"},{"key":"4427_CR3","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1805131","volume":"379","author":"MR Migden","year":"2018","unstructured":"Migden MR, Rischin D, Schmults CD et al (2018) PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma. N Engl J Med 379:341\u2013351. https:\/\/doi.org\/10.1056\/NEJMoa1805131","journal-title":"N Engl J Med"},{"key":"4427_CR4","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1200\/JCO.19.03054","volume":"38","author":"J-J Grob","year":"2020","unstructured":"Grob J-J, Gonzalez R, Basset-Seguin N et al (2020) Pembrolizumab monotherapy for recurrent or metastatic cutaneous squamous cell carcinoma: a single-arm phase II trial (KEYNOTE-629). J Clin Oncol 38:2916\u20132925. https:\/\/doi.org\/10.1200\/JCO.19.03054","journal-title":"J Clin Oncol"},{"key":"4427_CR5","unstructured":"Center for Drug Evaluation, Research FDA approves cemiplimab-rwlc for metastatic or locally advanced cutaneous squamous cell carcinoma. In: U.S. Food and Drug Administration. https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/fda-approves-cemiplimab-rwlc-metastatic-or-locally-advanced-cutaneous-squamous-cell-carcinoma. Accessed 30 Apr 2023"},{"key":"4427_CR6","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJMoa2209813","volume":"387","author":"ND Gross","year":"2022","unstructured":"Gross ND, Miller DM, Khushalani NI et al (2022) Neoadjuvant cemiplimab for stage II to IV cutaneous squamous-cell carcinoma. N Engl J Med 387:1557\u20131568. https:\/\/doi.org\/10.1056\/NEJMoa2209813","journal-title":"N Engl J Med"},{"key":"4427_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228\u2013247. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"4427_CR8","doi-asserted-by":"publisher","first-page":"100406","DOI":"10.1016\/j.bbih.2021.100406","volume":"19","author":"AC Chan","year":"2022","unstructured":"Chan AC, Tan BY, Goh Y et al (2022) Aseptic meningitis after BNT-162b2 COVID-19 vaccination. Brain Behav Immun Health 19:100406. https:\/\/doi.org\/10.1016\/j.bbih.2021.100406","journal-title":"Brain Behav Immun Health"},{"key":"4427_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-023-01391-8","author":"A Lin","year":"2023","unstructured":"Lin A, Schmalbach CE (2023) Surgery in the era of immunotherapy for advanced head and neck non-melanoma skin cancer. Curr Oncol Rep. https:\/\/doi.org\/10.1007\/s11912-023-01391-8","journal-title":"Curr Oncol Rep"},{"key":"4427_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-022-02358-y","author":"A Tiosano","year":"2023","unstructured":"Tiosano A, Ben-Ishai M, Cnaany Y et al (2023) Primary cemiplimab treatment for orbital squamous cell carcinoma is effective and may alleviate the need for orbital exenteration. Eye. https:\/\/doi.org\/10.1038\/s41433-022-02358-y","journal-title":"Eye"},{"key":"4427_CR11","doi-asserted-by":"publisher","first-page":"796197","DOI":"10.3389\/fonc.2021.796197","volume":"11","author":"LS McLean","year":"2021","unstructured":"McLean LS, Lim AM, Webb A et al (2021) Immunotherapy to avoid orbital exenteration in patients with cutaneous squamous cell carcinoma. Front Oncol 11:796197. https:\/\/doi.org\/10.3389\/fonc.2021.796197","journal-title":"Front Oncol"},{"key":"4427_CR12","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/hed.27005","volume":"44","author":"J Nightingale","year":"2022","unstructured":"Nightingale J, Gandhi M, Helena J et al (2022) Immunotherapy for the treatment of perineural spread in cutaneous head and neck squamous cell carcinoma: time to rethink treatment paradigms. Head Neck 44:1099\u20131105. https:\/\/doi.org\/10.1002\/hed.27005","journal-title":"Head Neck"},{"key":"4427_CR13","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1002\/lary.29953","volume":"132","author":"MP Wu","year":"2022","unstructured":"Wu MP, Reinshagen KL, Cunnane MB et al (2022) Clinical perineural invasion and immunotherapy for head and neck cutaneous squamous cell carcinoma. Laryngoscope 132:1213\u20131218. https:\/\/doi.org\/10.1002\/lary.29953","journal-title":"Laryngoscope"},{"key":"4427_CR14","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/hed.24607","volume":"39","author":"S Erkan","year":"2017","unstructured":"Erkan S, Savundra JM, Wood B et al (2017) Clinical perineural invasion of the trigeminal and facial nerves in cutaneous head and neck squamous cell carcinoma: outcomes and prognostic implications of multimodality and salvage treatment. Head Neck 39:1280\u20131286. https:\/\/doi.org\/10.1002\/hed.24607","journal-title":"Head Neck"},{"key":"4427_CR15","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","volume":"16","author":"F Martins","year":"2019","unstructured":"Martins F, Sofiya L, Sykiotis GP et al (2019) Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance. Nat Rev Clin Oncol 16:563\u2013580. https:\/\/doi.org\/10.1038\/s41571-019-0218-0","journal-title":"Nat Rev Clin Oncol"},{"issue":"Suppl 1","key":"4427_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/jdv.17402","volume":"36","author":"T Gambichler","year":"2022","unstructured":"Gambichler T, Scheel CH, Reuther J, Susok L (2022) Management of immune-related adverse events in anti-PD-1-treated patients with advanced cutaneous squamous cell carcinoma. J Eur Acad Dermatol Venereol 36(Suppl 1):23\u201328. https:\/\/doi.org\/10.1111\/jdv.17402","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04427-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-023-04427-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-023-04427-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T12:10:48Z","timestamp":1695730248000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-023-04427-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["4427"],"URL":"https:\/\/doi.org\/10.1007\/s11060-023-04427-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3220673\/v1","asserted-by":"object"}]},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"31 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}